Reed E - Search Results

1

Effects of interleukin-1 alpha on DNA repair in human ovarian carcinoma (NIH:OVCAR-3) cells: implications in the mechanism of sensitization of cis-diamminedichloroplatinum(II).

Benchekroun MN, Parker R, Dabholkar M, Reed E, Sinha BK. Benchekroun MN, et al. Among authors: reed e. Mol Pharmacol. 1995 Jun;47(6):1255-60. Mol Pharmacol. 1995. PMID: 7603468

2

Effect of cadmium on human ovarian cancer cells with acquired cisplatin resistance.

Lee KB, Parker RJ, Reed E. Lee KB, et al. Among authors: reed e. Cancer Lett. 1995 Jan 6;88(1):57-66. doi: 10.1016/0304-3835(94)03626-t. Cancer Lett. 1995. PMID: 7850774

3

Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cells.

Parker RJ, Dabholkar MD, Lee KB, Bostick-Bruton F, Reed E. Parker RJ, et al. Among authors: reed e. J Natl Cancer Inst Monogr. 1993;(15):83-8. J Natl Cancer Inst Monogr. 1993. PMID: 7912534

4

Inhibition of DNA repair and sensitization of cisplatin in human ovarian carcinoma cells by interleukin-1 alpha.

Benchekroun MN, Parker R, Reed E, Sinha BK. Benchekroun MN, et al. Among authors: reed e. Biochem Biophys Res Commun. 1993 Aug 31;195(1):294-300. doi: 10.1006/bbrc.1993.2044. Biochem Biophys Res Commun. 1993. PMID: 8363610

5

Sensitization by interleukin-1alpha of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cells in vitro and in vivo.

Wang Z, Lee KB, Reed E, Sinha BK. Wang Z, et al. Among authors: reed e. Int J Cancer. 1996 Nov 27;68(5):583-7. doi: 10.1002/(SICI)1097-0215(19961127)68:5<583::AID-IJC5>3.0.CO;2-V. Int J Cancer. 1996. PMID: 8938138

6

Alternative splicing of ERCC1 and cisplatin-DNA adduct repair in human tumor cell lines.

Yu JJ, Mu C, Dabholkar M, Guo Y, Bostick-Bruton F, Reed E. Yu JJ, et al. Among authors: reed e. Int J Mol Med. 1998 Mar;1(3):617-20. doi: 10.3892/ijmm.1.3.617. Int J Mol Med. 1998. PMID: 9852275

7

Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines.

Dabholkar M, Reed E. Dabholkar M, et al. Among authors: reed e. Cancer Lett. 1992 Apr 15;63(2):143-50. doi: 10.1016/0304-3835(92)90064-3. Cancer Lett. 1992. PMID: 1314131

8

Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell lines.

Dabholkar M, Parker R, Reed E. Dabholkar M, et al. Among authors: reed e. Mutat Res. 1992 Jun;274(1):45-56. doi: 10.1016/0921-8777(92)90042-2. Mutat Res. 1992. PMID: 1375331

9

Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.

Zhen W, Link CJ Jr, O'Connor PM, Reed E, Parker R, Howell SB, Bohr VA. Zhen W, et al. Among authors: reed e. Mol Cell Biol. 1992 Sep;12(9):3689-98. doi: 10.1128/mcb.12.9.3689-3698.1992. Mol Cell Biol. 1992. PMID: 1380646 Free PMC article.

10

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.

Parker RJ, Eastman A, Bostick-Bruton F, Reed E. Parker RJ, et al. Among authors: reed e. J Clin Invest. 1991 Mar;87(3):772-7. doi: 10.1172/JCI115080. J Clin Invest. 1991. PMID: 1999494 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,330 results

Search Page

Filters